Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN-Reference-Cited by-同舟云学术

Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN

Published:2021-11 Issue: Volume:110 Page:106646
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kricheldorf Kim^ORCID,Döhner Konstanze,Stegelmann Frank^ORCID,Jost Philipp J.,Lang Fabian,Radsak Markus,Hansen Richard,Heuer Vera,Röhrig Rainer^ORCID,Brümmendorf Tim H.^ORCID,Koschmieder Steffen^ORCID,Isfort Susanne^ORCID

Funder

Sanofi

Stiftung Universitätsmedizin Essen

Janssen Pharmaceuticals

Alexion Pharmaceuticals

Berlin Mathematical School

Celgene

Kommission für Technologie und Innovation

AbbVie

Daiichi-Sankyo

Roche

Shire

Takeda Pharmaceutical Company

Astellas Pharma US

Novartis

Amgen

Pfizer

Novartis Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. WHO Coronavirus Disease (COVID-19) Dashboard - Germany;World Health Organisation,2020

2. Bevölkerungsstand;Statistisches Bundesamt,2020

3. WHO Coronavirus Disease (COVID-19) Dashboard;World Health Organisation,2020

4. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS;Dreher;Arztebl. Int.,2020

5. Robert Koch Institut,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain;Annals of Hematology;2022-11-23

2. Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios;Cancers;2021-09-23